Pulse Biosciences, Inc. PLSE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74.57M-2.5% | -$72.78M+2.6% | -$74.73M-9.9% | -$68.03M-12.9% | -$60.24M-12.4% | ||
| $381K-7.1% | $410K-6.4% | $438K0.0% | $438K0.0% | $438K-3.3% | ||
| $17.69M-17.6% | $21.46M-7.8% | $23.28M+12.8% | $20.65M+17.9% | $17.51M+28.9% | ||
| —— | —— | —— | —— | —— | ||
| $176K+29.4% | $136K+139% | $57K+11.8% | $51K+70.0% | $30K— | ||
| —— | —— | $1.31M— | —— | —— | ||
| —— | —— | —— | —— | $1.72M-46.6% | ||
| —— | —— | —— | $372K+1,063% | $32K+3.2% | ||
| —— | —— | —— | —— | —— | ||
| $666K+0.2% | $665K0.0% | $665K-0.2% | $666K+0.2% | $665K-0.2% | ||
| $1.19M+2.9% | $1.15M+4.6% | $1.1M+5.9% | $1.04M— | —— | ||
| -$1.42M-3.9% | -$1.37M-4.7% | -$1.31M-6.4% | -$1.23M-6.8% | -$1.15M-6.9% | ||
| -$55.2M-2.0% | -$54.12M-11.6% | -$48.51M-9.0% | -$44.5M-11.0% | -$40.08M-10.3% | ||
| $303K-3.8% | $315K+19.8% | $263K+10.0% | $239K+44.8% | $165K+32.0% | ||
| -$323K+3.6% | -$335K-18.4% | -$283K-9.3% | -$259K-57.0% | -$165K-32.0% | ||
| $3.78M+52.0% | $2.49M+0.6% | $2.47M+99.3% | $1.24M-0.1% | $1.24M+42.6% | ||
| $4.56M-73.4% | $17.15M-73.6% | $64.98M-48.0% | $124.91M0.0% | $124.91M+13.1% | ||
| -$50.96M-36.6% | -$37.3M-331% | $16.18M-79.8% | $80.15M-5.0% | $84.39M+14.6% | ||
| $666K+0.2% | $665K0.0% | $665K-0.2% | $666K+0.2% | $665K-0.2% | ||
| $381K-7.1% | $410K-6.4% | $438K0.0% | $438K0.0% | $438K-3.3% | ||
| -$1.42M-3.9% | -$1.37M-4.7% | -$1.31M-6.4% | -$1.23M-6.8% | -$1.15M-6.9% | ||
| $760K-16.7% | $912K— | —— | —— | —— | ||
| $1.19M+2.9% | $1.15M+4.6% | $1.1M+5.9% | $1.04M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $57K— | $0-100% | $59K— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $167K-98.8% | $14.11M-77.2% | $61.98M-2.4% | $63.5M0.0% | $63.5M+28.5% | ||
| —— | —— | —— | —— | —— | ||
| -$1.42M-3.9% | -$1.37M-4.7% | -$1.31M-6.4% | -$1.23M-6.8% | -$1.15M-6.9% | ||
| —— | $0-100% | $207.5K-50.0% | $415K-33.3% | $622.5K-25.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $20.75K+59.6% | ||
| —— | —— | —— | —— | —— | ||
| -$55.5M-2.0% | -$54.44M-11.6% | -$48.77M-9.0% | -$44.74M-11.1% | -$40.25M-10.4% | ||
| -$55.5M-2.0% | -$54.44M-11.6% | -$48.77M-9.0% | -$44.74M-11.1% | -$40.25M-10.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pulse Biosciences, Inc. generate?
- Pulse Biosciences, Inc. (PLSE) generated -$55.2M in operating cash flow over the trailing twelve months.
- What is Pulse Biosciences, Inc.'s free cash flow?
- After $303.0K of capital expenditures, Pulse Biosciences, Inc.'s free cash flow was -$55.5M over the trailing twelve months, down 37.9% year over year.
- Where does Pulse Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
